BG25654A3 - Метод за получаване на инхибитори за гликозидхидролази от актиномицети - Google Patents

Метод за получаване на инхибитори за гликозидхидролази от актиномицети

Info

Publication number
BG25654A3
BG25654A3 BG019320A BG1932071A BG25654A3 BG 25654 A3 BG25654 A3 BG 25654A3 BG 019320 A BG019320 A BG 019320A BG 1932071 A BG1932071 A BG 1932071A BG 25654 A3 BG25654 A3 BG 25654A3
Authority
BG
Bulgaria
Prior art keywords
actinomycetes
glycoside hydrolases
obtaining inhibitors
inhibitors
obtaining
Prior art date
Application number
BG019320A
Other languages
Bulgarian (bg)
English (en)
Inventor
Werner Frommer
Walter Puls
Dietmar Schafer
Delf Schmidt
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG25654A3 publication Critical patent/BG25654A3/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/04—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/896—Streptomyces fradiae
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/907—Streptosporangium

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Mycology (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
BG019320A 1970-12-28 1971-12-24 Метод за получаване на инхибитори за гликозидхидролази от актиномицети BG25654A3 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2064092A DE2064092C2 (de) 1970-12-28 1970-12-28 Inhibitoren für Glykosidhydrolasen aus Actinomyceten

Publications (1)

Publication Number Publication Date
BG25654A3 true BG25654A3 (bg) 1978-11-10

Family

ID=5792372

Family Applications (3)

Application Number Title Priority Date Filing Date
BG019320A BG25654A3 (bg) 1970-12-28 1971-12-24 Метод за получаване на инхибитори за гликозидхидролази от актиномицети
BG025075A BG26003A4 (bg) 1970-12-28 1973-11-26 Метод за получаване на инхибитори за гликозид-хидролази от актиномицети
BG025074A BG26002A4 (bg) 1970-12-28 1973-11-26 Метод за получаване на инхибитори за гликозид-хидролази от актиномицети

Family Applications After (2)

Application Number Title Priority Date Filing Date
BG025075A BG26003A4 (bg) 1970-12-28 1973-11-26 Метод за получаване на инхибитори за гликозид-хидролази от актиномицети
BG025074A BG26002A4 (bg) 1970-12-28 1973-11-26 Метод за получаване на инхибитори за гликозид-хидролази от актиномицети

Country Status (28)

Country Link
US (1) US3876766A (zh)
JP (3) JPS5734996B1 (zh)
KR (1) KR780000248B1 (zh)
AR (1) AR193370A1 (zh)
AT (1) AT330122B (zh)
AU (1) AU461521B2 (zh)
BE (1) BE777387A (zh)
BG (3) BG25654A3 (zh)
CA (1) CA979833A (zh)
CH (1) CH594051A5 (zh)
CS (1) CS167961B2 (zh)
DD (1) DD99395A5 (zh)
DE (1) DE2064092C2 (zh)
DK (1) DK139533C (zh)
ES (1) ES398358A1 (zh)
FI (1) FI49774C (zh)
FR (1) FR2120073B1 (zh)
GB (1) GB1374751A (zh)
IE (1) IE35920B1 (zh)
IL (1) IL38441A (zh)
LU (1) LU64319A1 (zh)
NL (1) NL175199C (zh)
NO (1) NO135873C (zh)
PL (1) PL82900B1 (zh)
RO (3) RO61400A (zh)
SE (1) SE398357B (zh)
SU (1) SU454750A3 (zh)
ZA (1) ZA718677B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2209833C3 (de) * 1972-03-01 1978-06-01 Bayer Ag, 5090 Leverkusen Herstellung eines Amylaseinhibitors
DE2209834C3 (de) * 1972-03-01 1978-04-20 Bayer Ag, 5090 Leverkusen Herstellung von Saccharase-Inhibitoren
DE2209832C3 (de) * 1972-03-01 1979-03-29 Bayer Ag, 5090 Leverkusen Herstellung von Saccharaseinhibitoren
US4062950A (en) * 1973-09-22 1977-12-13 Bayer Aktiengesellschaft Amino sugar derivatives
US4010258A (en) * 1974-03-15 1977-03-01 Ajinomoto Co., Inc. Microbial amylase inhibitor and preparation thereof with the use of streptomyces diasticus var. amylostaticus
US4065557A (en) * 1974-03-21 1977-12-27 Bayer Aktiengesellschaft Amino sugars and their use in improving the meat:fat ratio in animals
US4065562A (en) * 1975-12-29 1977-12-27 Nippon Shinyaku Co., Ltd. Method and composition for reducing blood glucose levels
FR2338707A1 (fr) * 1976-01-22 1977-08-19 Rhone Poulenc Ind Nouvel inhibiteur de glyco-hydrolases et sa preparation par culture d'un streptomyces
DE2658563A1 (de) * 1976-12-23 1978-06-29 Bayer Ag Inhibitoren fuer glykosid-hydrolasen aus bacillen
DE2701890C2 (de) * 1977-01-19 1983-08-04 Hoechst Ag, 6230 Frankfurt Peptielischer Glycosidhydrolase-Inhibitor aus einem Streptomyceten und seine Verwendung
DE2719912C3 (de) * 1977-05-04 1979-12-06 Bayer Ag, 5090 Leverkusen Verfahren zur Isolierung von 0- |4,6-Dideoxy-4- [JJl S-O,4,6/5)-4,5,6-trihydroxy-3-hydroxymethyl-2cyclohexen-1-yl] -amino] - a -D-glucopyranosyl} -(I Pfeil nach rechts 4)-0- a D-glucopyranosyl-(l Pfeil nach rechts 4)-D-glucopyranose aus Kulturbrühen
GB2016497A (en) * 1978-02-10 1979-09-26 Taisho Pharmaceutical Co Ltd Microbiological production of amylase inhibitor
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
JPS62160696A (ja) * 1986-01-07 1987-07-16 シャープ株式会社 電子式自動点滅器
ATE89563T1 (de) * 1986-08-13 1993-06-15 Hoechst Ag Oxiran-pseudooligosaccharide, verfahren zu deren herstellung, deren verwendung und pharmazeutische praeparate.
US5464828A (en) * 1988-03-02 1995-11-07 Chugai Pharmaceutical Co., Ltd. Aqueous suspension of sucralfate
DE19507214A1 (de) * 1995-03-02 1996-10-31 Bayer Ag Acarbose-Biosynthesegene aus Actinoplanes sp., Verfahren zu ihrer Isolierung sowie ihre Verwendung
EP0796915A3 (de) * 1996-03-22 1999-04-14 Bayer Ag Verfahren zur Herstellung sowie zur Verwendung von Acarviosyl-Transferase bei der Umwandlung von Acarbose-Homologen in Acarbose, zur Herstellung von Acarbose-Homologen
DE19637591A1 (de) * 1996-09-13 1998-03-19 Bayer Ag Osmokontrolliertes Fermentationsverfahren zur Herstellung von Acarbose
DE10085149B4 (de) 1999-10-28 2008-06-19 Chong Kun Dang Pharmaceutical Corp. Verfahren zur Herstellung von Acarbose mit hohem Reinheitsgrad
HRP20010792A2 (en) 2001-10-26 2003-04-30 Pliva D D Acarbose purification process
KR20140109922A (ko) 2011-12-08 2014-09-16 바이엘 인텔렉쳐 프로퍼티 게엠베하 연관된 방선균의 유전적 형질전환을 위한 플라스미드인 액티노플라네스 sp. SE50/110으로부터 유래한 신규한 방선균류 통합 및 접합 인자
US9345727B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component and uses thereof
US8889633B2 (en) 2013-03-15 2014-11-18 Mead Johnson Nutrition Company Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof
US9345741B2 (en) 2013-03-15 2016-05-24 Mead Johnson Nutrition Company Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof
US9352020B2 (en) 2013-03-15 2016-05-31 Mead Johnson Nutrition Company Reducing proinflammatory response
US9138455B2 (en) 2013-03-15 2015-09-22 Mead Johnson Nutrition Company Activating adiponectin by casein hydrolysate
US9289461B2 (en) 2013-03-15 2016-03-22 Mead Johnson Nutrition Company Reducing the risk of autoimmune disease
EP4045520A1 (en) 2019-10-16 2022-08-24 Bayer Aktiengesellschaft Methods for the improved formation of acarbose
WO2021195087A1 (en) 2020-03-23 2021-09-30 Bay State Milling Company Rapid high amylose wheat seed purity test

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3127315A (en) * 1964-03-31 Hypocholesterolemic agent m-

Also Published As

Publication number Publication date
AR193370A1 (es) 1973-04-23
JPS5734996B1 (zh) 1982-07-26
RO61400A (zh) 1977-01-15
DD99395A5 (zh) 1973-08-05
JPS57150395A (en) 1982-09-17
LU64319A1 (zh) 1972-06-13
ES398358A1 (es) 1974-09-01
FI49774C (fi) 1975-10-10
NO135873C (zh) 1977-06-15
AU461521B2 (en) 1975-05-29
BG26003A4 (bg) 1979-01-12
DE2064092A1 (de) 1972-07-20
FR2120073A1 (zh) 1972-08-11
US3876766A (en) 1975-04-08
SE398357B (sv) 1977-12-19
DK139533B (da) 1979-03-05
RO63065A (fr) 1979-02-15
DE2064092C2 (de) 1983-06-01
NL175199B (nl) 1984-05-01
IE35920B1 (en) 1976-06-23
JPS57150396A (en) 1982-09-17
AT330122B (de) 1976-06-10
DK139533C (da) 1979-08-20
JPS6234396B2 (zh) 1987-07-27
IE35920L (en) 1972-06-28
IL38441A0 (en) 1972-02-29
ATA1111571A (de) 1975-09-15
GB1374751A (en) 1974-11-20
BG26002A4 (bg) 1979-01-12
ZA718677B (en) 1972-09-27
CA979833A (en) 1975-12-16
NL175199C (nl) 1984-10-01
BE777387A (fr) 1972-06-28
IL38441A (en) 1974-10-22
FR2120073B1 (zh) 1975-12-26
NO135873B (zh) 1977-03-07
NL7117893A (zh) 1972-06-30
KR780000248B1 (en) 1978-07-06
CS167961B2 (zh) 1976-05-28
PL82900B1 (zh) 1975-10-31
FI49774B (zh) 1975-06-30
AU3721471A (en) 1973-09-27
RO63064A (fr) 1978-06-15
CH594051A5 (zh) 1977-12-30
JPS6216638B2 (zh) 1987-04-14
SU454750A3 (ru) 1974-12-25

Similar Documents

Publication Publication Date Title
BG26003A4 (bg) Метод за получаване на инхибитори за гликозид-хидролази от актиномицети
BG20365A3 (bg) Метод за получаване на производни на бензилпиримидина
BG21025A3 (bg) Метод за получаване на производни на 2-пиролидинона
BG20100A3 (bg) Метод за получаване на 1-фенокси-2-хидрокси-3- хидроалкил-аминопропани
BG21016A3 (bg) Метод за получаване на фениламиноалкани
BG19373A3 (bg) Метод за получаване на тиокарбамиди
BG20610A3 (bg) Метод за получаване на триазени
SU430549A3 (ru) Способ получения ацетилироваипых производных гликозидов
BG19138A3 (bg) Метод за получаване на фенилкарбамиди
BG17788A3 (bg) Метод за получаване на производни на пропан-3-оса
BG18860A3 (bg) Метод за получаване на бензамидни производни
BG18416A3 (bg) Метод за получаване на n-винилхинолони
BG20555A3 (bg) Метод за получаване на n-изопропил-анилин
BG17979A3 (bg) Метод за получаване на дез- фенила- ланин в1- инсулин
BG17963A3 (bg) Метод за получаване на нови карденалид- рамнозиди
BG19122A3 (bg) Метод за получаване на борнаминови производни
BG17574A3 (bg) Метод за получаване на изохинолинови производни
BG20355A3 (bg) Метод за получаване на тетрахидроизохинолинови производни
BG21020A3 (bg) Метод за получаване на n-субституирани ацеталдимини
BG20571A3 (bg) Метод за получаване на сулфанилкарбамиди
BG17530A3 (bg) Метод за получаане на алкиламинопропани
BG17967A3 (bg) Метод за получаване на изохинолинови производни
BG18870A3 (bg) Метод за получаване на нови 2-амино-дихидро- бензодиазепинони
BG16584A3 (bg) Метод за получаване на нови аминопропиофенони
BG17578A3 (bg) Метод за получаване на 5- нитро- фурилови производни